Home Tags Medicine
medicine Related Content
In the fourth of a series of five articles, Oxford Cannabinoid Technologies discuss their expertise on cannabinoids in medicine.
Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.
L. Maximilian Buja, MD, Professor of Pathology and Laboratory Medicine at McGovern Medical School, The University of Texas Health Science Center at Houston, turns the spotlight onto medical education both past and present.
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
In recognition of World Glaucoma Week, The Association of British Dispensing Opticians (ABDO) highlights how a simple eye test is a key way to detect Glaucoma.
An international research team has made a breakthrough in stroke treatment, with a drug that could stop brain swelling without invasive surgery.
A new study has identified that vitamin D deficiency is one of the key causes of increased disc degeneration and lower back pain.
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
Here, we look at MRI research on brain abnormalities that could be the biological reason behind depression.
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Here, we discover that the European Medicines Agency works to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public and animal health in the European Union.
In the view of Amanda Feilding, Founder of the Beckley Foundation, “Psychedelics are unique pharmacological compounds that hold the promise of a profound paradigm shift in psychiatry.” Here, we learn about the Psychedelic Renaissance and the importance of drug policy reform.
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
Brendan Crossey, Chief Executive Officer of Healthcare Analytics Limited, directs our thoughts to innovative bed tracking at the Northern Health and Social Care Trust, one of five health and social care trusts in Northern Ireland.
Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.
PTC Therapeutics have announced the use of a blood test for the rare genetic condition, aromatic L-amino acid decarboxylase (AADC) deficiency.
Only 11% of Brits see antimicrobial resistance as a serious threat to society, despite the outgoing UK Chief Medical Officer saying earlier this year that Superbugs “could kill us before climate change does”.
Charles Kinney, Communications Manager, EFA, argues that the policymakers have a long way to go addressing the reality of life with asthma and COPD.
Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.
Swarms of nanoparticles which are 15,000 times smaller than a pinhead may be able to deliver vital drugs to the brain, offering new hope to stroke patients.